CARMAT announces the first commercial implant of its Aeson artificial heart

An artificial heart by French manufacturer Carmat is seen during an interview with Reuters in Velizy, near Paris, January 11, 2021. REUTERS/Christian Hartmann

PARIS, July 19 (Reuters) - French artificial heartmaker CARMAT (ALCAR.PA) announced on Monday the first commercial implant of its Aeson artificial heart at a hospital in Italy, which the company said paved the way for its further commercial development.

Last week, CARMAT had announced the first human implant of its Aeson bioprosthetic artificial heart in the United States.

Reporting by Sudip Kar-Gupta

Our Standards: The Thomson Reuters Trust Principles.